(Q43204887)

16 November 2017

'First dose' hypotension and venodilatation (English)

1 reference

16 November 2017

Capewell S

1

1 reference

PMCID

1368400

16 November 2017

Capewell A

series ordinal

2

1 reference

PMCID

1368400

16 November 2017

language of work or name

English

0 references

publication date

1 February 1991

1 reference

British Journal of Clinical Pharmacology

16 November 2017

1 reference

16 November 2017

31

1 reference

16 November 2017

2

1 reference

16 November 2017

213-215

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

16 November 2017

1 reference

Study of single and multiple dose pharmacokinetic/pharmacodynamic modeling of the antihypertensive effects of labetalol

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

A radionuclide method for the simultaneous study of the effects of drugs on central and peripheral haemodynamics

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Profound hypotension after the first dose of ketanserin

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Why does vasodilatation occur during syncope?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Severe hypotension after first dose of enalapril in heart failure

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

The effect of captopril on the reflex control heart rate: possible mechanisms

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Captopril in congestive cardiac failure

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Acute and chronic arterial and venous effects of captopril in congestive cardiac failure

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Profound hypotension after atenolol in severe hypertension

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Prazosin: the first-dose phenomenon

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Captopril therapy for heart failure. A placebo controlled study.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368400

Relative importance of venous and arterial resistances in controlling venous return and cardiac output

15 August 2018

1 reference

12 December 2020

Radionuclide evaluation of peripheral circulatory dynamics: new clinical application of blood pool scintigraphy for measuring limb venous volume, capacity, and blood flow

1 reference

12 December 2020

Vasodilator therapy of severe congestive heart failure: The special importance of angiotensin-converting enzyme inhibition with captopril

1 reference

12 December 2020

Hemodynamic effects of a competitive renin inhibitory peptide in humans: evidence for multiple mechanisms of action

1 reference

12 December 2020

Vasovagal reactions to cardiovascular drugs: the first dose effect

1 reference

12 December 2020

Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy

1 reference

12 December 2020

10.1111/J.1365-2125.1991.TB05522.X

Identifiers

DOI

1 reference

16 November 2017

1 reference

16 November 2017

1 reference

PMCID

1368400